[1]JAJOSKY A,FELS ELLIOTT DR.Esophageal cancer genetics and clinical translation[J].Thorac Surg Clin,2022,32(4):425-435.
[2]XIE Y,SHI X,CHEN Y,et al.The intra-class heterogeneity of immunophenotyping and immune landscape in oesophageal cancer and clinical implications[J].Ann Med,2021,53(1):626-638.
[3]RAEISI M,ZEHTABI M,VELAEI K,et al.Anoikis in cancer:The role of lipid signaling[J].Cell Biol Int,2022,46(11):1717-1728.
[4]MENENDEZ JA,LUPU R.Fatty acid synthase:a druggable driver of breast cancer brain metastasis[J].Expert Opin Ther Targets,2022,26(5):427-444.
[5]POLONIO-ALCALA E,PALOMERAS S,TORRES-OTEROS D,et al.Fatty acid synthase inhibitor G28 shows anticancer activity in EGFR tyrosine kinase inhibitor resistant lung adenocarcinoma models[J].Cancers(Basel),2020,12(5):1283.
[6]SCHCOLNIK-CABRERA A,DUENAS-GONZALEZ A.Mouse model for efficient simultaneous targeting of glycolysis,glutaminolysis,and de novo synthesis of fatty acids in colon cancer[J].Methods Mol Bio,2021,2174:45-69.
[7]FHU CW,ALI A.Fatty acid synthase:an emerging target in cancer[J].Molecules,2020,25(17):3935.
[8]ROGERS JE,SEWASTJANOW-SILVA M,WATERS RE,et al.Esophageal cancer:emerging therapeutics[J].Expert Opin Ther Targets,2022,26(2):107-117.
[9]LI Y,XU F,CHEN F,et al.Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma[J].EbioMedicine,2021,70:103510.
[10]GUNENC AN,GRAF B,STARK H,et al.Fatty acid synthase:structure,function,and regulation[J].Subcell Biochem,2022,99:1-33.
[11]HUO X,SONG L,LI D,et al.Landscape of the oncogenic role of fatty acid synthase in human tumors[J].Aging(Albany NY),2021,13(23):25106-25137.
[12]WANG X,TIAN J,ZHAO Q,et al.Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma[J].Arch Toxicol,2020,94(6):2039-2046.
[13]苏红,司晓宇,唐文如,等.失巢凋亡及其在肿瘤侵袭、转移中的调控[J].遗传,2013,35(1):10-16.
SU H,SI XY,TANG WR,et al.The regulation of anoikis in tumor invasion and metastasis[J].Hereditas,2013,35(1):10-16.
[14]TIAN T,LU Y,LIN J,et al.CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis[J].Redox Biol,2022,58:102544.
[15]ZHU JF,LIU Y,HUANG H,et al.MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth[J].Cancer Cell Int,2018,18:193.
[16]LIN YT,WU KJ.Epigenetic regulation of epithelial-mesenchymal transition:focusing on hypoxia and TGF-β signaling[J].J Biomed Sci,2020,27(1):39.
[17]CHO ES,KANG HE,KIM NH,et al.Therapeutic implications of cancer epithelial-mesenchymal transition(EMT)[J].Arch Pharm Res,2019,42(1):14-24.
[18]GOBIN E,BAGWELL K,WAGNER J,et al.A pan-cancer perspective of matrix metalloproteases(MMP) gene expression profile and their diagnostic/prognostic potential[J].BMC Cancer,2019,19(1):581.
[19]SONG Z,WANG J,SU Q,et al.The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma[J].Braz J Otorhinolaryngol,2021,87(5):521-528.